The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-09
DOI
10.1038/s41416-021-01377-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
- (2021) Jiali Yu et al. NATURE MEDICINE
- Systemic Inflammation and Outcome in 2295 Patients with Stage I–III Colorectal Cancer from Scotland and Norway: First Results from the ScotScan Colorectal Cancer Group
- (2020) James H. Park et al. ANNALS OF SURGICAL ONCOLOGY
- Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases
- (2020) Stefan Stremitzer et al. BRITISH JOURNAL OF CANCER
- Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
- (2020) Samarth Hegde et al. CANCER CELL
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
- (2020) Thierry André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatocytes direct the formation of a pro-metastatic niche in the liver
- (2019) Jae W. Lee et al. NATURE
- The Prognostic Value of a Pathologic Complete Response After Neoadjuvant Therapy for Digestive Cancer: Systematic Review and Meta-Analysis of 21 Studies
- (2019) Tao Wan et al. ANNALS OF SURGICAL ONCOLOGY
- The Intersection between Tumor Angiogenesis and Immune Suppression
- (2019) Osama E. Rahma et al. CLINICAL CANCER RESEARCH
- Metastasis Organotropism: Redefining the Congenial Soil
- (2019) Yang Gao et al. DEVELOPMENTAL CELL
- Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
- (2019) Emmanouil Fokas et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarker-guided therapy for colorectal cancer: strength in complexity
- (2019) Anita Sveen et al. Nature Reviews Clinical Oncology
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis
- (2019) Scott J Antonia et al. LANCET ONCOLOGY
- Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy
- (2019) Abhishek S. Kashyap et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer
- (2019) Elodie Lauret Marie Joseph et al. Cancer Immunology Research
- The impact of rectal cancer tumor height on recurrence rates and metastatic location: A competing risk analysis of a national database
- (2018) Knut M. Augestad et al. Cancer Epidemiology
- Radiotherapy and CD40 activation separately augment immunity to checkpoint blockade in cancer
- (2018) Andrew J Rech et al. CANCER RESEARCH
- The promise and challenges of immune agonist antibody development in cancer
- (2018) Patrick A. Mayes et al. NATURE REVIEWS DRUG DISCOVERY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Signal interaction between the tumour and inflammatory cells in patients with gastrointestinal cancer: Implications for treatment
- (2018) Kathryn A.F. Pennel et al. CELLULAR SIGNALLING
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
- (2016) Erta Kalanxhi et al. BMC CANCER
- From tumour heterogeneity to advances in precision treatment of colorectal cancer
- (2016) Cornelis J. A. Punt et al. Nature Reviews Clinical Oncology
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Serum soluble CD40 is associated with liver injury in patients with chronic hepatitis B
- (2015) HONG-HUI SHEN et al. Experimental and Therapeutic Medicine
- The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review
- (2014) Gui Lee et al. CURRENT CANCER DRUG TARGETS
- Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY Study
- (2013) Fiona G.M. Taylor et al. JOURNAL OF CLINICAL ONCOLOGY
- Macrophages and chemokines as mediators of angiogenesis
- (2013) Jennifer L. Owen et al. Frontiers in Physiology
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poking CD40 for cancer therapy, another example of the Goldilocks effect
- (2011) Joseph J. Drabick et al. CANCER BIOLOGY & THERAPY
- Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
- (2011) Jens Rüter et al. CANCER BIOLOGY & THERAPY
- Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
- (2010) Monique Maas et al. LANCET ONCOLOGY
- Rectal cancer staging post neoadjuvant therapy - how should the changes be assessed?
- (2009) Adrian C Bateman et al. HISTOPATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now